investorscraft@gmail.com

Stock Analysis & ValuationTAO Synergies Inc. (TAOX)

Previous Close
$4.27
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

1185 Avenue of the Americas, 3rd Floor
New York 10036
United States
Industry: Biotechnology
Sector: Healthcare
CEO: Joshua N. Silverman
Full Time Employees: 4

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

HomeMenuAccount